David Callanan
Ophthalmology · Arlington, TXNPI 1558360339
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $50,335 of the $58,699 with a category attached, or 85.8%. 14 manufacturers reported payments, led by Eyepoint US, Inc. at 31.9% of the total. Reporting peaked in 2019 at $49,074 and has fallen 99.5% since, to $224 in 2022. Among ophthalmology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 54 payments — averaging $1087.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eyepoint US, Inc.$19K
- AbbVie$15K
- Shire North American Group Inc$8K
- Genentech, Inc.$6K
- Takeda Pharmaceuticals U.S.A., Inc.$5K
- F. Hoffmann-la Roche AG$4K
- plus $2K from 8 others
Across 107 payments — averaging $19,112 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$1M
- Novartis$569K
- Regeneron$215K
- Amgen$123K
- AbbVie$70K
- Aerie Pharmaceuticals, Inc.$42K
- plus $14K from 2 others
What the payments were for
- Consulting fees$50,33586%
- Speaking & faculty fees$5,59110%
- Travel & lodging$6671%
- Food & beverage$2,1054%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eyepoint US, Inc. | 17 | $18,718 |
| AbbVie | 12 | $14,925 |
| Shire North American Group Inc | 4 | $7,830 |
| Genentech, Inc. | 6 | $5,844 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $5,390 |
| F. Hoffmann-la Roche AG | 2 | $3,691 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $1,500 |
| Alimera Sciences, Inc. | 3 | $335 |
| Regeneron | 1 | $132 |
| Regeneron Healthcare Solutions, Inc. | 1 | $119 |
| Novartis | 3 | $104 |
| Alcon | 1 | $64 |
| Mallinckrodt Enterprises LLC | 1 | $30 |
| Genentech USA, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$58,699 in reported general payments places this provider in the 95th percentile of 1,355 ophthalmology providers in Texas.
Other ophthalmology in Arlington
- Aaleya KoreishiArlington$144K
- Michael SingerSan Antonio$1.8M
- Oluwatosin SmithDallas$1.5M
- Charles WykoffBellaire$1.5M
- John MichelettiHouston$916K
- Davinder GroverDallas$705K
- Christina WengHouston$676K
- Peter ChangHouston$656K
- Zaina Al-MohtasebHouston$636K
- Ashkan AbbeyDallas$559K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.